海角社区

Paper calendar with yellow pencil laying on top of it. Link to course schedule

View courses by theme or by week

Large group shot of people who participated in the courses in 2019 looking up into the camera. link to registration information

See fees and deadlines

Link to Frequently Asked Questions page

Get answers to all your questions

Global Point-of-care Diagnostics: Ideation, Implementation & Impact听|听June 2-3, 2026听

COURSE FORMAT

Online only. Course will be live to online participants approximately 8:00 AM to 2:00 PM (Montreal time) each day June 2-3, 2026. All content will be recorded and accessible to participants until July 1, 2026.

DESCRIPTION

The field of point-of-care diagnostics (POC Dx) gained international attention in 2020, when the world recognised the impact that rapid point-of-care tests and self-tests could have on screening for a respiratory pathogen鈥攈elping to keep us all at home. Laypeople came to distinguish between screening and diagnosis, between POC rapid tests and portable molecular POC tests, and between self-tests and lab-based tests. This nuanced appreciation by the general public was a significant win for the field of diagnostics, and POC Dx quietly arrived on the global stage. Since 2020, we have observed a ripple effect across the field of POC Dx.

In 2026, POC Dx are advanced, innovative, connected, integrated, and impactful and the field is ready to expand its reach worldwide.

Scope:

This advanced course will provide you with an update on the latest developments in POC Dx. You will gain up-to-date knowledge of key trends, identify unmet needs in the field, and benefit from shared insights designed for the learner community. We will explore developments in novel technologies, connected and digital diagnostics, innovative techniques, and conceptual approaches, and examine their impact on patient care worldwide. Together, we will cover advances ranging from nanotechnology and quantum technologies to CRISPR-Cas assays, as well as molecular diagnostics and genomics/precision diagnostics. You will be exposed to a range of approaches鈥攆rom design thinking and needs assessment to product development, from evaluation methods to regulatory essentials, and from commercialisation to scaling through service delivery models designed to generate clinical and public health impact.

To meet your learning needs, we will bring together global experts in POC Dx from both the Global North and the Global South, with experience spanning the full spectrum of POC diagnostics, from development to deployment. Through interactive panel sessions and case studies, you will enhance your understanding, strengthen your strategies, and gain a global perspective to address real-world POC Dx challenges. These experts will share invaluable experience, scientific research, and practical insights to guide your POC Dx journey.

The course will include interactive learning exercises, panel discussions with experts and opportunity for Q&A.

COURSE DIRECTORS

Senior Scientist, Research Institute at 海角社区 Health Centre听

Centre for Outcomes Research and Evaluation

Professor, Department of Medicine, Faculty of Medicine and Health Sciences, 海角社区

Department of Medicine, Division of Clinical Epidemiology, MUHC

Trevor Peter, PhD

Senior Scientific Director听

Laboratory Services at the Clinton Health Access Initiative

CONTENT

  • Product development and design thinking

  • Adaptive needs assessment in the era of AI

  • Methods and evaluative approaches in POC Dx

  • Novel technologies: quantum technologies, CRISPR-Cas systems, and genomics

  • Implementation of diagnostic initiatives: a health agency approach

  • Showcase of novel, connected, and integrated technologies

TARGET AUDIENCE

  • Academic and entrepreneurial research and development leaders interested in transitioning into infectious disease diagnostic product development

  • R&D managers and scientists in early-stage diagnostic companies and academic research groups

  • Graduate students in bioengineering and infectious disease research interested in diagnostic development

  • Academic innovation hubs and industry accelerators

  • Scientists and managers, including:

    • Funding agency staff and grant or contract reviewers

    • Product Development Partnership (PDP) professionals

    • Public health agency policymakers and implementers

ENROLMENT

Limited to 100 online participants.

Back to top